| Quarterly Financials | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Jun 2021 | Sept 2021 |
Revenue  | 8 | 8 | 7 | 11 | 10 | 10 | 5 | 7 | 10 | 10 |
| Expenses | 8 | 8 | 8 | 9 | 10 | 10 | 5 | 7 | 8 | 10 |
| EBITDA | 1 | 0 | -1 | 2 | 1 | -0 | -0 | 0 | 2 | 1 |
| Operating Profit % | 8 % | 2 % | -16 % | 17 % | 4 % | -5 % | -8 % | 2 % | 16 % | 5 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 0 | -1 | 2 | 0 | -0 | -0 | 0 | 2 | 0 |
| Tax | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 0 | -1 | 2 | 0 | -1 | -0 | 0 | 2 | 0 |
| EPS in ₹ | 0.77 | 0.49 | 0.00 | 2.28 | 0.50 | 0.00 | -0.60 | -0.02 | 2.16 | 0.61 |
Gujarat Terce Laboratories
Gujarat Terce Laboratories
43.95
+0.88
(2.04%)
Key Fundamentals
Market Cap
14.08 Cr
EPS
-1.32
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare 52 Week High
92.22
52 Week Low
37.20
PB Ratio
4.17
Debt to Equity
0.35
Sector
Pharmaceuticals Actual
Company News
View All News
Gujarat Terce Laboratories Reports Mixed Q2 Results with Record EBITDA Despite Revenue Decline
Nov 08, 2025
Nov 08, 2025Gujarat Terce Laboratories Limited reported quarterly results showing revenue of Rs 1,292.63 lacs compared to Rs 1,330.12 lacs in the previous year, marking a 2.82% decrease. Despite the revenue decline, the company achieved its highest EBITDA performance in history at Rs 194.46 lacs versus Rs 174.21 lacs, representing an 11.62% increase. Net profit decreased by 5.30% to Rs 140.36 lacs from Rs 148.22 lacs. EBITDA margin improved to 15.04% from 13.10%, while PAT margin decreased slightly to 10.86% from 11.14%. The company attributes the revenue reduction to planned scale-down of low-margin factory B2B sales and rationalization of certain non-profitable operations. Management highlighted that the company completed three quarters without external funding, operating through internal accruals and improved cash discipline. The pharmaceutical company operates 8 leading brands across 134 products, with presence in 13 states and 224 districts through 385 stockists and 147 medical representatives.
Gujarat Terce Laboratories Reports Quarterly Financial Results for Period Ended September 30, 2025Nov 08, 2025
Gujarat Terce Laboratories Limited announced its unaudited standalone financial results for the second quarter and half year ended September 30, 2025. The Board of Directors approved the results during a meeting held on November 8, 2025. The company reported revenue from operations of Rs. 1,202.63 lakhs for the quarter, with total revenue of Rs. 1,298.18 lakhs. The company posted a profit before tax of Rs. 78.34 lakhs for the quarter. Basic earnings per share stood at Rs. 0.59 for the quarter. The company operates in the pharmaceutical segment. The results were subject to limited review by statutory auditors M.A. Shah & Co., who issued an unmodified limited review report.
Gujarat Terce Laboratories Limited approved its unaudited standalone financial results for the quarter ended June 30, 2025. The pharmaceutical company reported a net loss of Rs 4.35 lakhs compared to a loss of Rs 7.76 lakhs in the same quarter last year. Revenue from operations declined to Rs 1,085.36 lakhs from Rs 1,188.88 lakhs year-over-year. The company's earnings per share stood at -Rs 0.06 for the quarter. The board also approved the reconstitution of three key committees - Audit Committee, Nomination and Remuneration Committee, and Stakeholders' Relationship Committee, with new compositions featuring independent directors in leadership roles. The statutory auditors M.A. Shah & Co. provided an unmodified opinion on the quarterly results.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,781.70 | #1 4,27,489.51 | 40.68 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 71.49 | |
6,391.50 | 1,69,674.24 | 69.05 | 9,712.00 | 18.67 | 2,191 | 35.10 | 47.34 | |
3,687.30 | 1,24,794.99 | 58.80 | 11,539.40 | 6.99 | 1,911 | 30.46 | 54.89 | |
1,517.20 | 1,22,552.45 | 22.73 | 28,409.50 | 7.12 | 5,291 | 3.71 | 48.01 | |
1,247.20 | 1,04,093.03 | #1 18.15 | 33,741.20 | 16.73 | 5,725 | -0.38 | 53.56 | |
926.25 | 93,202.42 | 18.56 | 23,511.00 | 18.55 | 4,615 | 34.60 | 33.23 | |
2,032.00 | 92,812.52 | 21.34 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 58.77 | |
2,241.70 | 92,528.07 | 52.05 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 32.96 | |
1,210.10 | 70,282.80 | 20.70 | 32,345.60 | 9.43 | 3,484 | 3.81 | 63.26 | |
5,693.00 | 68,068.35 | 28.29 | 13,458.30 | 3.70 | 2,216 | 10.98 | 60.35 |
Growth Rate
Revenue Growth
4.55 %
Net Income Growth
-600.00 %
Cash Flow Change
17.69 %
ROE
-540.52 %
ROCE
240.97 %
EBITDA Margin (Avg.)
152.28 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 26 | 25 | 24 | 20 | 19 | 23 | 22 | 27 | 29 | 23 | 23 |
| Fixed Assets | 7 | 6 | 6 | 2 | 2 | 2 | 3 | 4 | 4 | 4 | 4 |
| Current Assets | 17 | 15 | 13 | 10 | 9 | 12 | 12 | 16 | 16 | 11 | 12 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Other Assets | 20 | 18 | 17 | 17 | 17 | 20 | 19 | 23 | 24 | 19 | 19 |
| Total Liabilities | 26 | 25 | 24 | 20 | 19 | 23 | 22 | 27 | 29 | 23 | 23 |
| Current Liabilities | 8 | 7 | 6 | 7 | 7 | 9 | 12 | 13 | 17 | 12 | 13 |
| Non Current Liabilities | 8 | 8 | 8 | 2 | 2 | 2 | 3 | 6 | 5 | 4 | 4 |
| Total Equity | 11 | 10 | 10 | 10 | 11 | 11 | 8 | 9 | 7 | 7 | 7 |
| Reserve & Surplus | 4 | 3 | 3 | 3 | 3 | 4 | 0 | 1 | -1 | -0 | -1 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 1 | -1 | 0 | 0 | -1 | -0 | 1 | 0 | 1 | -2 | 1 |
| Investing Activities | 0 | -0 | 0 | 1 | -0 | -0 | -0 | -1 | 1 | -1 | 1 |
| Operating Activities | 1 | 0 | 0 | 5 | -1 | -2 | -0 | -0 | 0 | 3 | 3 |
| Financing Activities | -1 | -1 | -0 | -5 | 0 | 2 | 2 | 2 | -0 | -4 | -3 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 35.74 % | 35.85 % | 36.22 % | 36.22 % | 36.22 % | 36.22 % | 36.22 % | 36.22 % | 36.45 % | 36.65 % | 36.78 % | 37.01 % | 37.03 % | 37.03 % | 37.03 % | 37.03 % | 37.03 % | 37.03 % | 37.03 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 59.15 % | 59.01 % | 59.02 % | 56.41 % | 56.64 % | 59.15 % | 58.76 % | 58.97 % | 58.47 % | 57.78 % | 57.49 % | 58.47 % | 59.92 % | 59.87 % | 59.62 % | 59.44 % | 59.34 % | 59.12 % | 58.49 % |
| Others | 5.11 % | 5.14 % | 4.77 % | 7.37 % | 7.14 % | 4.63 % | 5.02 % | 4.82 % | 5.07 % | 5.58 % | 5.74 % | 4.53 % | 3.05 % | 3.10 % | 3.35 % | 3.53 % | 3.63 % | 3.85 % | 4.48 % |
| No of Share Holders | 0 | 13,295 | 13,321 | 13,277 | 13,320 | 13,406 | 13,670 | 13,599 | 13,625 | 13,499 | 13,404 | 13,327 | 13,203 | 13,394 | 13,538 | 13,710 | 13,764 | 13,804 | 13,812 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 25 Apr 2024 |  Extraordinary General Meeting | NA | 25 Apr 2024 | 52.95 | 67.45 |
| 17 Sept 2024 |  Annual General Meeting | NA | 17 Sept 2024 | 52.51 | 74.96 |
| 28 Oct 2024 |  Quarterly Result Announcement | NA | 28 Oct 2024 | 80.29 | 73.00 |
| 04 Feb 2025 | Quarterly Result Announcement | NA | 04 Feb 2025 | 84.85 | 79.70 |
| 26 May 2025 | Quarterly Result Announcement | NA | 26 May 2025 | 57.12 | 55.65 |
| 11 Aug 2025 | Quarterly Result Announcement | NA | 11 Aug 2025 | 49.15 | 47.51 |
| 21 Aug 2025 | Annual General Meeting | NA | 21 Aug 2025 | 49.29 | 43.42 |
| 08 Nov 2025 | Quarterly Result Announcement | NA | 08 Nov 2025 | 45.75 | 45.98 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 08, 2025
Nov 08, 2025Unaudited Standalone Financial Results Of The Company Forthe Second Quarter And Half Year Ended 30 September2025 - Regulations 30 And 33 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 08, 2025
Nov 08, 2025Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Board Meeting Held On 8 November 2025Nov 08, 2025
Nov 08, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone Financial Results Of The Company For The Second Quarter And Half Year Ended 30 September 2025Nov 02, 2025
Nov 02, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Oct 10, 2025Closure of Trading WindowOct 01, 2025
Oct 01, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 01, 2025
Sep 01, 2025Appointment of Company Secretary and Compliance OfficerSep 01, 2025
Sep 01, 2025Announcement under Regulation 30 (LODR)-CessationSep 01, 2025
Sep 01, 2025Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Board Meeting Held On 1 September 2025 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - CSep 01, 2025
Sep 01, 2025 Shareholders Meeting - 40Th AGM Scrutinizer Report Along With Voting ResultsAug 22, 2025
Aug 22, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 21, 2025
Aug 21, 2025Announcement Under Regulation 30 Of SEBI (LODR)- Cessation Of Mrs. Chhayaben Shah (DIN: 01435892) Independent Director Due To Expiry Of TermAug 21, 2025
Aug 21, 2025Cessation Of Mrs. Chhayaben Shah (DIN: 01435892) Independent Director Due To Expiry Of TermAug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 12, 2025
Aug 12, 2025 Un-Audited Financial Results For The Quarter Ended 30.06.2025Aug 11, 2025
Aug 11, 2025Board Meeting Outcome for Outcome Of Board Meeting To Approve The Unaudited Standalone Financial Results For The Quarter Ended 30.06.2025Aug 11, 2025
Aug 11, 2025Board Meeting Intimation for Board Meeting Intimation For Consideration Of Unaudited Financial Results For The Quarter Ended 30Th June 2025Aug 04, 2025
Aug 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 30, 2025
Jul 30, 2025Reg. 34 (1) Annual Report.Jul 28, 2025
Jul 28, 2025Pursuant To Regulation 30 Of The SEBI Listing Regulations We Wish To Inform You That The 40Th Annual General Meeting (AGM) Of The Company Will Be Held On Thursday 21St Day Of August 2025 At 01.00 P.M. Through Video Conferencing / Other Audio-Visual MeansJul 26, 2025
Jul 26, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 17Th July 2025.Jul 17, 2025
Jul 17, 2025Non-Applicability Of Regulation 27(2) Of SEBI (LODR) Regulations 2015 For The Quarter
Ended On June 30 2025.Jul 16, 2025
Jul 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 11, 2025
Jul 11, 2025Board Meeting Intimation for Approval Of Draft Notice Of 40Th Annual General Meeting.Jul 09, 2025
Jul 09, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 26, 2025
May 26, 2025Appointment Of DirectorMay 26, 2025
May 26, 2025Results-Financial Results For The Year Ended 31.03.2025May 26, 2025
May 26, 2025Board Meeting Outcome for Outcome Of Board Meeting_Audited Financial Results 31.03.2025May 26, 2025
May 26, 2025Update on board meetingMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-CessationMay 21, 2025
May 21, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 21, 2025
May 21, 2025Board Meeting Intimation for Approval Of Audited Financial Results For Quarter And Year Ended On 31St March 2025May 19, 2025
May 19, 2025Disclosure Of Non-Applicability Of SEBI Circular Dated 26Th November 2018 With Regard To Fund Raising By Issuance Of Debt Securities By Large Entities.Apr 18, 2025
Apr 18, 2025Non-Applicability Of Corporate Governance Under Regulation 27(2) Of SEBI (LODR) Regulations 2015 For The Quarter And Financial Year Ended 31St March 2025.Apr 11, 2025
Apr 11, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Closure of Trading WindowMar 25, 2025
Mar 25, 2025Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateMar 12, 2025
Mar 12, 2025Integrated Filing (Financial)Mar 06, 2025
Mar 06, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 10, 2025
Feb 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2025
Feb 06, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 04, 2025
Feb 04, 2025Results - Unaudited For Quarter Ended 31.12.2024Feb 04, 2025
Feb 04, 2025Board Meeting Outcome for Quarterly Unaudited Financial Results For Quarter Ended On 31.12.2024Feb 04, 2025
Feb 04, 2025Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results Of The Company For The Quarter Ended On 31St December 2024Jan 27, 2025
Jan 27, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2025
Jan 16, 2025Technical Indicators
RSI(14)
Neutral 42.53
ATR(14)
Less Volatile 3.14
STOCH(9,6)
Neutral 25.12
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -0.43
ADX(14)
Weak Trend 11.13
UO(9)
Bearish 36.86
ROC(12)
Downtrend And Accelerating -7.40
WillR(14)
Neutral -79.01
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
